These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 15868932

  • 1. Osteogenic progenitor cell potency after high-dose chemotherapy (COSS-96).
    Jäger M, Schultheis A, Westhoff B, Krauspe R.
    Anticancer Res; 2005; 25(2A):947-54. PubMed ID: 15868932
    [Abstract] [Full Text] [Related]

  • 2. [Goal and results of the COSS study].
    Flege S, Bielack S.
    Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):282-8. PubMed ID: 15503258
    [Abstract] [Full Text] [Related]

  • 3. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, Müller C, Tienghi A, Wiebe T, Comandone A, Böhling T, Del Prever AB, Brosjö O, Bacci G, Saeter G, Italian and Scandinavian Sarcoma Groups.
    J Clin Oncol; 2005 Dec 01; 23(34):8845-52. PubMed ID: 16246977
    [Abstract] [Full Text] [Related]

  • 4. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
    Eselgrim M, Grunert H, Kühne T, Zoubek A, Kevric M, Bürger H, Jürgens H, Mayer-Steinacker R, Gosheger G, Bielack SS.
    Pediatr Blood Cancer; 2006 Jul 01; 47(1):42-50. PubMed ID: 16206218
    [Abstract] [Full Text] [Related]

  • 5. [Neoadjuvant chemotherapy of osteosarcoma. Preliminary results of the cooperative COSS-86 osteosarcoma study].
    Bieling P, Bielack S, Delling G, Jürgens H, Kotz R, Dose C, Astheimer H, Exner G, Gadner H, Graf N.
    Klin Padiatr; 1991 Jul 01; 203(4):220-30. PubMed ID: 1942929
    [Abstract] [Full Text] [Related]

  • 6. Neoadjuvant chemotherapy for pediatric osteosarcoma patients.
    Uchida A, Myoui A, Araki N, Yoshikawa H, Shinto Y, Ueda T.
    Cancer; 1997 Jan 15; 79(2):411-5. PubMed ID: 9010116
    [Abstract] [Full Text] [Related]

  • 7. Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study.
    Thiele OC, Freier K, Bacon C, Egerer G, Hofele CM.
    Br J Oral Maxillofac Surg; 2008 Oct 15; 46(7):533-6. PubMed ID: 18436357
    [Abstract] [Full Text] [Related]

  • 8. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
    Bielack S, Kempf-Bielack B, Schwenzer D, Birkfellner T, Delling G, Ewerbeck V, Exner GU, Fuchs N, Göbel U, Graf N, Heise U, Helmke K, von Hochstetter AR, Jürgens H, Maas R, Münchow N, Salzer-Kuntschik M, Treuner J, Veltmann U, Werner M, Winkelmann W, Zoubek A, Kotz R.
    Klin Padiatr; 1999 Oct 15; 211(4):260-70. PubMed ID: 10472560
    [Abstract] [Full Text] [Related]

  • 9. [Neoadjuvant chemotherapy for osteosarcoma].
    Guo W, Yang RL, Tang XD, Tang S, Li DS, Yang Y.
    Zhonghua Yi Xue Za Zhi; 2004 Jul 17; 84(14):1186-90. PubMed ID: 15387981
    [Abstract] [Full Text] [Related]

  • 10. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
    Bacci G, Longhi A, Forni C, Fabbri N, Briccoli A, Barbieri E, Mercuri M, Balladelli A, Ferrari S, Picci P.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):505-11. PubMed ID: 17118571
    [Abstract] [Full Text] [Related]

  • 11. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.
    Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier H.
    J Clin Oncol; 2005 Mar 20; 23(9):2004-11. PubMed ID: 15774791
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
    Zalupski MM, Rankin C, Ryan JR, Lucas DR, Muler J, Lanier KS, Budd GT, Biermann JS, Meyers FJ, Antman K.
    Cancer; 2004 Feb 15; 100(4):818-25. PubMed ID: 14770440
    [Abstract] [Full Text] [Related]

  • 13. A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis.
    Patel SR, Papadopolous N, Raymond AK, Donato M, Seong CM, Yasko AW, Lewis VO, Lin PP, Champlin R, Benjamin RS.
    Cancer; 2004 Jul 01; 101(1):156-63. PubMed ID: 15222001
    [Abstract] [Full Text] [Related]

  • 14. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
    Cohen IJ.
    Pediatr Hematol Oncol; 2003 Dec 01; 20(8):579-81. PubMed ID: 14578026
    [Abstract] [Full Text] [Related]

  • 15. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
    Kudawara I, Aoki Y, Ueda T, Araki N, Naka N, Nakanishi H, Matsumine A, Ieguchi M, Mori S, Myoui A, Kuratsu S, Hashimoto N, Yoshikawa H.
    J Chemother; 2013 Feb 01; 25(1):41-8. PubMed ID: 23433444
    [Abstract] [Full Text] [Related]

  • 16. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE, Children's Oncology Group.
    J Clin Oncol; 2008 Feb 01; 26(4):633-8. PubMed ID: 18235123
    [Abstract] [Full Text] [Related]

  • 17. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
    Bacci G, Ferrari S, Tienghi A, Bertoni F, Mercuri M, Longhi A, Fiorentini G, Forni C, Bacchini P, Rimondini S, De Giorgi U, Picci P.
    Eur J Surg Oncol; 2001 Feb 01; 27(1):98-104. PubMed ID: 11237499
    [Abstract] [Full Text] [Related]

  • 18. Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro.
    Jäger M, Fischer J, Dohrn W, Li X, Ayers DC, Czibere A, Prall WC, Lensing-Höhn S, Krauspe R.
    J Orthop Res; 2008 Nov 01; 26(11):1440-8. PubMed ID: 18404732
    [Abstract] [Full Text] [Related]

  • 19. [Neoadjuvant chemotherapy of osteosarcoma. Results of the cooperative studies COSS-80 and COSS-82 after 7 and 5 years].
    Bielack S, Beck J, Delling G, Gerein V, Grümayer R, Hiddemann W, Jobke A, Jürgens H, Kornhuber G, Kotz R.
    Klin Padiatr; 1989 Nov 01; 201(4):275-84. PubMed ID: 2674532
    [Abstract] [Full Text] [Related]

  • 20. [Chemotherapy of osteosarcoma].
    Winkler K, Bieling P, Bielack S.
    Z Orthop Ihre Grenzgeb; 1992 Nov 01; 130(4):285-9. PubMed ID: 1413973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.